• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光辅助经皮免疫以靶向人体皮肤树突状细胞。

Laser-assisted epicutaneous immunization to target human skin dendritic cells.

机构信息

Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.

Department of Plastic, Reconstructive and Aesthetic Surgery, Medical University of Innsbruck, Innsbruck, Austria.

出版信息

Exp Dermatol. 2021 Sep;30(9):1279-1289. doi: 10.1111/exd.14346. Epub 2021 May 3.

DOI:10.1111/exd.14346
PMID:33797121
Abstract

Dendritic cells (DC) are promising targets for immunotherapy of cancer. Clinically, immunization against cancer antigens by means of the most potent antigen-presenting cells, that is DC, remains an important treatment option in combination with the modern immune checkpoint approaches. Instead of adoptively transferring in vitro monocyte-derived DC, they can also be loaded in situ by antibody-mediated targeting of antigen. Conventionally, these vaccines are delivered by classical intradermal injections. Here, we tested an alternative approach, namely laser-assisted epicutaneous immunization. With an infrared laser ("Precise Laser Epidermal System"/P.L.E.A.S.E. Laser System), we created micropores in human skin and applied monoclonal antibodies (mAbs) against C-type lectins, for example DEC-205/CD205 and Langerin/CD207. Optimal parameters for formation of pores in epidermis and dermis were determined. We could induce pores of defined depths without enhanced apoptosis around them. Antibodies applied epicutaneously to the laser-porated skin could be detected both in Langerhans cells (LC) in situ in the epidermis and in migratory skin DC subsets from short term human skin explant culture, demonstrating uptake and transport of Langerin and DEC-205 mAbs. Efficacy of targeting was similar between the different laser treatments and pore depths. Thus, laser-assisted epicutaneous immunization may be a valuable alternative to intradermal injection, yet the loading efficacy of DC needs to be further improved.

摘要

树突状细胞(DC)是癌症免疫治疗的有前途的靶点。临床上,通过最有效的抗原呈递细胞(即 DC)对癌症抗原进行免疫接种仍然是与现代免疫检查点方法相结合的重要治疗选择。除了过继转移体外单核细胞衍生的 DC 外,还可以通过抗体介导的抗原靶向原位加载。传统上,这些疫苗通过经典的皮内注射给药。在这里,我们测试了一种替代方法,即激光辅助经皮免疫。我们使用红外激光(“精密激光表皮系统”/P.L.E.A.S.E.激光系统)在人体皮肤中创建微孔,并应用针对 C 型凝集素的单克隆抗体(mAb),例如 DEC-205/CD205 和 Langerin/CD207。确定了在表皮和真皮中形成孔的最佳参数。我们可以在不增加周围细胞凋亡的情况下诱导具有定义深度的孔。应用于激光穿孔皮肤的抗体可在表皮中的原位朗格汉斯细胞(LC)和短期人皮肤外植体培养中的迁移性皮肤 DC 亚群中检测到,表明 Langerin 和 DEC-205 mAb 的摄取和转运。不同激光处理和孔深度之间的靶向效率相似。因此,激光辅助经皮免疫可能是皮内注射的有价值替代方法,但 DC 的负载效率需要进一步提高。

相似文献

1
Laser-assisted epicutaneous immunization to target human skin dendritic cells.激光辅助经皮免疫以靶向人体皮肤树突状细胞。
Exp Dermatol. 2021 Sep;30(9):1279-1289. doi: 10.1111/exd.14346. Epub 2021 May 3.
2
Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors.通过皮内注射针对凝集素受体的抗体,可在原位靶向人类皮肤树突状细胞。
Exp Dermatol. 2014 Dec;23(12):909-15. doi: 10.1111/exd.12573.
3
Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.皮肤 langerin+树突状细胞可转运皮内注射的抗 DEC-205 抗体,但对随后的细胞毒性 CD8+T 细胞应答并非必需。
J Immunol. 2012 Mar 1;188(5):2146-55. doi: 10.4049/jimmunol.1004120. Epub 2012 Jan 30.
4
Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.用抗原性蛋白质靶向表皮朗格汉斯细胞:利用其特性进行免疫治疗的尝试。
Cancer Immunol Immunother. 2009 Jul;58(7):1137-47. doi: 10.1007/s00262-008-0563-9. Epub 2008 Aug 2.
5
Expression of C-type lectin receptors by subsets of dendritic cells in human skin.人类皮肤中树突状细胞亚群的C型凝集素受体表达
Int Immunol. 2004 Jun;16(6):877-87. doi: 10.1093/intimm/dxh088. Epub 2004 Apr 27.
6
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.通过将 HIV gag p24 靶向到朗格汉斯细胞、DEC205 和 Clec9A 抗体中的 CD8 树突状细胞,实现可比的辅助性 T 细胞 1(Th1)和 CD8 T 细胞免疫。
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2384-9. doi: 10.1073/pnas.1019547108. Epub 2011 Jan 24.
7
Single chain antibody fragments for the selective targeting of antigens to dendritic cells.用于将抗原选择性靶向树突状细胞的单链抗体片段。
Mol Immunol. 2005 May;42(8):979-85. doi: 10.1016/j.molimm.2004.09.034. Epub 2004 Dec 10.
8
Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.表皮朗格汉斯细胞能够迅速捕获并递呈真皮中 C 型凝集素靶向抗体所沉积的抗原。
J Invest Dermatol. 2010 Mar;130(3):755-62. doi: 10.1038/jid.2009.343. Epub 2009 Nov 5.
9
Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.通过 langerin 和 DC-SIGN 靶向的交叉呈递需要不同形式的糖基化修饰抗原。
J Control Release. 2015 Apr 10;203:67-76. doi: 10.1016/j.jconrel.2015.01.040. Epub 2015 Feb 2.
10
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo.一种纯化的 DEC-205 导向抗体与全长蛋白的化学偶联,用于体外和体内靶向小鼠树突状细胞。
J Vis Exp. 2021 Feb 5(168). doi: 10.3791/62018.

引用本文的文献

1
Innovative delivery systems for epicutaneous immunotherapy.经皮免疫治疗的创新给药系统。
Front Immunol. 2023 Aug 22;14:1238022. doi: 10.3389/fimmu.2023.1238022. eCollection 2023.
2
Glycomimetics for the inhibition and modulation of lectins.糖基模拟物抑制和调节凝集素。
Chem Soc Rev. 2023 Jun 6;52(11):3663-3740. doi: 10.1039/d2cs00954d.
3
Interoperability of RTN1A in dendrite dynamics and immune functions in human Langerhans cells.RTN1A 在人朗格汉斯细胞树突动态和免疫功能中的互操作性。
Elife. 2022 Oct 12;11:e80578. doi: 10.7554/eLife.80578.
4
Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C-type lectin receptor Langerin.通过 C 型凝集素受体 langerin 将疫苗蛋白靶向递送至人皮肤中的朗格汉斯细胞。
Eur J Immunol. 2022 Nov;52(11):1829-1841. doi: 10.1002/eji.202149670. Epub 2022 Jan 9.